drugset / Trial / NCT00752791

Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.

NCT00752791

Phase 2 Completed 59 enrolled Takeda Affymax · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the efficacy and safety of peginesatide injection for maintenance treatment of anemia in participants on peritoneal dialysis.

Timeline

Start
2008-10
Primary completion
2010-05
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject peginesatide Peptide 0.04 mg/kg
Subject peginesatide Peptide 0.16 mg/kg

Indications